Atrás
Rango del Día
$15.00
$16.74
Rango de 52 Semanas
$7.76
$71.50
Volumen
2,341,352
Promedio 50D / 200D
$20.69
/
$25.16
Cierre Anterior
$16.09
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -4.9 | 0.4 |
| P/B | 4.9 | 2.9 |
| ROE % | -207.1 | 3.8 |
| Net Margin % | -1236.0 | 3.9 |
| Rev Growth 5Y % | -58.1 | 10.0 |
| D/E | 2.7 | 0.2 |
Precio Objetivo de Analistas
Hold
$41.80
+162.6%
Low: $11.00
High: $95.00
EPS Futuro
-$3.49
Ingresos Est.
32 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.52
$0.37 – $3.90
|
580 M | 5 |
| FY2029 |
-$0.56
-$1.44 – -$0.14
|
370 M | 2 |
| FY2028 |
-$2.61
-$4.42 – $1.21
|
180 M | 7 |
Puntos Clave
Revenue declined -58.13% annually over 5 years
Debt/Equity of 2.70 — high leverage
Negative free cash flow of -177.96M
PEG of 0.23 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 17.49%
Capital efficient — spends only 2.73% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-58.13%
Revenue (1Y)-40.64%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-207.10%
ROIC-18.91%
Net Margin-1236.00%
Op. Margin-1152.13%
Seguridad
Debt / Equity
2.70
Current Ratio10.43
Interest Coverage-2.99
Valoración
P/E Ratio
-4.93
P/B Ratio4.93
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -40.64% | Revenue Growth (3Y) | 0.80% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -58.13% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 16.10M | Net Income (TTM) | -198.97M |
| ROE | -207.10% | ROA | -24.12% |
| Gross Margin | -2.16% | Operating Margin | -1152.13% |
| Net Margin | -1236.00% | Free Cash Flow (TTM) | -177.96M |
| ROIC | -18.91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.70 | Current Ratio | 10.43 |
| Interest Coverage | -2.99 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.93 | P/B Ratio | 4.93 |
| P/S Ratio | 60.92 | PEG Ratio | 0.23 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 980.73M | Enterprise Value | 1.44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 16.10M | 27.12M | 15.84M | 106.48M | 524.00M |
| Net Income | -198.97M | -239.56M | -308.48M | -126.79M | 329.59M |
| EPS (Diluted) | -3.46 | -4.92 | -6.47 | -2.71 | 7.04 |
| Gross Profit | -347,000.0 | 8.79M | 2.22M | 103.14M | 499.03M |
| Operating Income | -185.47M | -184.29M | -282.87M | -143.16M | 310.62M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 824.91M | 556.54M | 831.69M | 704.96M | 809.18M |
| Total Liabilities | 626.01M | 563.29M | 624.02M | 228.96M | 213.40M |
| Shareholders' Equity | 198.90M | -6.75M | 207.67M | 476.01M | 595.78M |
| Total Debt | 536.59M | 66.06M | 138.41M | 142.89M | 135.72M |
| Cash & Equivalents | 80.24M | 158.93M | 241.36M | 228.01M | 556.26M |
| Current Assets | 655.99M | 390.29M | 651.85M | 476.77M | 628.24M |
| Current Liabilities | 62.92M | 40.05M | 73.68M | 75.92M | 36.76M |